Guidance for the notification of serious breaches of GCP or the trial protocol
Table of Contents
Page Number(s):
D. Arrangements for notification
E. Identifying serious breaches
F. Potential actions by the MHRA
Appendix I: Notification Examples
Appendix II: Notification Form
Clinical Research News
即将进行的临床试验
-
NCT04584255招聘中条件：Stage I Breast Cancer, 二期最高, 三期糖尿病, 褐色, HER2阴性糖尿病, 胚芽BRCA1基因突变, 生殖系BRCA2基因突变
-
NCT04644016招聘中条件：AML, 全部, MDS, MPD伴骨髓纤维化, NHL或HL, 遗传性代谢紊乱, 血红蛋白病, 骨髓衰竭, HLH
-
NCT04708431招聘中条件：Androgen Insensitivity Syndrome, AIS，CAIS，PAIS和MAIS中的代谢参数, AIS，CAIS，PAIS和MAIS中的肿瘤形成, 性功能AIS，CAIS，PAIS和MAIS
-
NCT04242264尚未招聘条件：Immunisation, nära Spanien
-
NCT04525599招聘中条件：Healthy Volunteers, 肺炎球菌病
-
NCT04535167招聘中条件：病毒性疾病
-
NCT00024635招聘中条件：Mood Disorder, 忧症, 健康志愿者, 躁郁症, 破坏
-
NCT04665037招聘中条件：侵袭性骨折感染
-
NCT03983837尚未招聘条件：Chronic Granulomatous Disease, 抗生素性肠病
-
NCT04221178招聘中条件：浆细胞骨髓瘤
Recent CRA jobs
-
Scheduling Coordinator
-
Sales Liaison - Remote - West Coast
-
Principal Consultant Health Economics Modelling (UK/EU locations)
-
Senior Records Management Associate
-
AD/D, Integrated Solution Strategist (Clinical Operation)
-
Sr. Scientist 1
-
Senior Consultant Pricing & Market Access (UK/EU locations)
-
Patient Advocacy Group Manager
-
Brand Marketing Director
-
Senior Clinical Research Associate A